Corcept Therapeutics IncorporatedCORTNASDAQ
Loading
Operating Margin Over TimeContracting
Percentile Rank31
3Y CAGR-40.6%
5Y CAGR-30.5%
Year-over-Year Change
Operating income as a percentage of revenue
3Y CAGR
-40.6%/yr
vs -5.8%/yr prior
5Y CAGR
-30.5%/yr
Recent deceleration
Acceleration
-34.8pp
Decelerating
Percentile
P31
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
6 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | 5.88% | -71.0% |
| 2024 | 20.29% | -8.8% |
| 2023 | 22.24% | -20.7% |
| 2022 | 28.03% | -17.6% |
| 2021 | 34.01% | -6.1% |
| 2020 | 36.23% | -0.5% |
| 2019 | 36.41% | +2.2% |
| 2018 | 35.62% | +7.3% |
| 2017 | 33.20% | +165.2% |
| 2016 | 12.52% | - |